Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
24 September, 2018 12:41 IST
Lupin receives tentative USFDA nod for generic Locoid lotion
Source: IRIS | 12 Feb, 2018, 04.20PM
Comments  |  Post Comment

Pharma major Lupin announced that it has received tentative approval for its Hydrocortisone Butyrate Lotion, 0.1% from the United States Food and Drug Administration (FDA) to market a generic version of Precision Dermatology, Inc.'s Locoid Lotion, 0.1%.

Lupin's Hydrocortisone Butyrate Lotion, 0.1% is the generic equivalent of Precision Dermatology, Inc.'s Locoid Lotion, 0.1%. It is indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.

Hydrocortisone Butyrate Lotion, 0.1% had annual sales of approximate USD 16.1 million in the US (IQVIA MAT October 2017).

Shares of the company gained Rs 18.4, or 2.24%, to settle at Rs 839.30. The total volume of shares traded was 124,365 at the BSE (Monday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Tatas to acquire Usha Martin's steel business for up to Rs 47 bn - 24-Sep-2018 10:05
Sequent Scientific to acquire Solara Active Pharma Sciences' EU-GMP API facility - 24-Sep-2018 09:48
Biocon announces successful USFDA inspection of its Bangalore facility - 24-Sep-2018 09:45
Godrej Properties adds a new residential project in Noida, NCR - 24-Sep-2018 09:42
ITD Cementation India wins orders worth Rs 8.45 bn - 21-Sep-2018 15:44
Emami Paper Mills to invest around Rs 20 bn in Gujarat - 21-Sep-2018 15:03
Tijaria Polypipes receives single order worth Rs 353 mn - 21-Sep-2018 13:13
Infosys to open technology and innovation hub in Arizona - 21-Sep-2018 13:08
Pennar Group bags orders worth Rs 1.81 bn - 21-Sep-2018 13:05
TCS recognized as leader in finance and accounting digital augmentation suite - 21-Sep-2018 12:30
Sun Pharma announces Australian TGA approval of ILUMYA - 21-Sep-2018 12:06
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer